Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ishares A.I. Innovation and Tech Active ETF (BAI)

Ishares A.I. Innovation and Tech Active ETF (BAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 6,683,258,000
  • Shares Outstanding, K 206,720
  • 60-Month Beta 2.60
  • Price/Earnings ttm 39.95
  • Annual Dividend & Yield 0.60 (1.85%)
  • Most Recent Dividend 0.593 on 12/16/25
  • Management Fee 0.55%

Options Overview Details

View History
  • Implied Volatility 79.51% (+0.91%)
  • Historical Volatility 36.64%
  • IV Percentile 98%
  • IV Rank 95.70%
  • IV High 82.69% on 04/10/25
  • IV Low 8.84% on 09/02/25
  • Expected Move (DTE 1) 1.13 (3.50%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 16
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 378
  • Open Int (30-Day) 427
  • Expected Range 31.20 to 33.46

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.82 +4.90%
on 11/21/25
35.96 -10.09%
on 12/10/25
-0.59 (-1.79%)
since 11/18/25
3-Month
30.82 +4.90%
on 11/21/25
38.04 -15.01%
on 10/29/25
-2.43 (-6.99%)
since 09/18/25
52-Week
18.33 +76.38%
on 04/07/25
38.04 -15.01%
on 10/29/25
+5.20 (+19.17%)
since 12/18/24

Most Recent Stories

More News
DeepSeek Shakes US Tech Dominance: Impact on Stocks & ETFs

The technology sector, which had been enjoying a huge AI boom, saw a bloodbath on Monday, triggered by the emergence of DeepSeek, a China-based artificial intelligence (AI) startup that threatens to disrupt...

NVDA : 174.14 (+1.87%)
DAPP : 16.55 (+1.35%)
SMCL : 4.63 (-3.18%)
PSI : 77.50 (+2.43%)
SEMI : 29.76 (-2.52%)
ARTY : 46.80 (+1.65%)
BAI : 32.33 (+2.37%)
AIS : 35.99 (+2.75%)
TSMY : 14.83 (+1.23%)
SMHX : 36.96 (+1.54%)
SMH : 347.25 (+2.36%)
SHOC : 66.15 (+2.38%)
BenevolentAI: Notice of Preliminary Results

BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leading, clinical-stage AI-enabled drug discovery company, will announce its preliminary results for the year ended 31...

BAI : 32.33 (+2.37%)
BenevolentAI to Present at the Cowen 43rd Annual Health Care Conference

BenevolentAI ​​(Euronext Amsterdam: BAI), a leading clinical-stage AI drug discovery company, announces that it will present at the Cowen 43rd Annual Health Care Conference, which will be held in Boston...

BAI : 32.33 (+2.37%)
BenevolentAI to Present at 41st Annual J.P. Morgan Healthcare Conference

BenevolentAI ​​(Euronext Amsterdam: BAI), a leading clinical-stage AI drug discovery company, announces that it will participate in the upcoming 41st Annual J.P. Morgan Healthcare Conference in San...

BAI : 32.33 (+2.37%)
BenevolentAI Group: Analyst / Investor Event and Interim Results

/PRNewswire/ -- BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leading, clinical-stage AI-enabled drug discovery company, is...

BAI : 32.33 (+2.37%)
BenevolentAI Group: Notice of Interim Results and Analyst / Investor Event

/PRNewswire/ -- BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leading, clinical-stage AI-enabled drug discovery company, will...

BAI : 32.33 (+2.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Fund Summary

The iShares A.I. Innovation and Tech Active ETF seeks to maximize total return.

See More

Key Turning Points

3rd Resistance Point 33.12
2nd Resistance Point 32.88
1st Resistance Point 32.60
Last Price 32.33
1st Support Level 32.09
2nd Support Level 31.85
3rd Support Level 31.57

See More

52-Week High 38.04
Last Price 32.33
Fibonacci 61.8% 30.51
Fibonacci 50% 28.19
Fibonacci 38.2% 25.86
52-Week Low 18.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar